MARKET RESEARCH
-
As monsoon takes hold, anti-infective, respiratory drugs' demand surges
​According to market research firm Pharmatrack, the respiratory market was driven by anti-asthma and chronic obstructive pulmonary disease (COPD) products, along with cough and cold preparations. The market also witnessed close to 200% growth for Poractant Alfa usage (pulmonary surfactant) in July.
-
Organovo's drug significantly reduces liver fat in NASH study
-
Close to 40 per cent physicians prescribe branded drugs to their patients
-
Cell and gene therapy to have greatest impact on pharmaceutical industry in 2024: GlobalData
-
Top challenges for pharma in 2024: Lingering inflation, geopolitical tensions, continuous pressures to cut drug prices
-
Zyla clocks 3X growth in 12 months, aims further expansion
Join the community of 2M+ industry professionals
Subscribe to our Daily Newsletter
Advertisement
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
